continue

Translr App Announces New Strategies to Help Reduce Gender Disclosure Anxiety for Transgender Users

New York, New York, June 19, 2025 (GLOBE NEWSWIRE) -- As debates around gender history disclosure continue to spark controversy…

2 weeks ago

Arcontech Excelerator. A performant, stress-free alternative to migrating to LSEG Workspace Excel Add-in

LONDON, June 17, 2025 /PRNewswire/ -- For the thousands of financial professionals who rely on the established functionality and market sheets…

2 weeks ago

Embracing Powertrain Diversity, GWM Continues to Enhance Clean Diesel Capabilities for Off-Roading

BAODING, China--(BUSINESS WIRE)--While new energy vehicles continue to gain momentum worldwide, efficient diesel power remains a compelling choice—especially in challenging…

3 weeks ago

PSP Investments continues track record of strong returns and portfolio resilience with a 12.6% return in fiscal 2025, net assets approach $300 billion

Five and 10-year net annualized returns of 10.6% and 8.2%.$31.9 billion in cumulative net investment gains above the Reference Portfolio…

3 weeks ago

CGTN: China-U.S. trade talks in London receive positive market reception

With the first meeting of the China-U.S. economic and trade consultation mechanism set to continue in London on Tuesday, CGTN…

3 weeks ago

XCMG Releases New Energy Light Truck Series Hanjie, Promotes Transformation of Green Transportation

XUZHOU, China, June 10, 2025 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE:000425) has recently released the new generation new energy light…

3 weeks ago

T.D. Williamson Announces Strategic Investment from Apollo Funds

TULSA, Okla., June 10, 2025 /PRNewswire/ -- T.D. Williamson ("TDW"), a global leader in pipeline infrastructure technology and services, announced…

3 weeks ago

Manufacturers and Logistics Providers Embrace AI for Enhanced Barcode Reading Performance

Survey reveals 90% of users anticipate AI will improve accuracy, ease of use, decode rates, and more NATICK, Mass., June…

4 weeks ago

DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer

TROPION-Lung02 and TROPION-Lung04 phase 1b results support combination of Daiichi Sankyo and AstraZeneca’s DATROWAY with immunotherapy as first-line treatment for…

1 month ago